[1] Luttmer R, De Strooper LM, Steenbergen RD, et al. Management of high-risk HPV-positive women for detection of cervical (pre)cancer[J].Expert Rev Mol Diagn,2016,16(9):961-974. [2] 唐璞,黄早胜.磁共振动态增强联合弥散加权成像评估宫颈癌盆腔淋巴转移的价值研究[J].医学临床研究,2020,37(4):631-633. [3] Celewicz A, Celewicz M, Wezowska M, et al. Clinical efficacy of p16/Ki-67 dual-stained cervical cytology in secondary prevention of cervical cancer[J].Pol J Pathol,2018,69(1):42-47. [4] Byun SW, Lee A, Kim S, et al. Immunostaining of p16(INK4a)/Ki-67 and L1 capsid protein on liquid-based cytology specimens obtained from ASC-H and LSIL-H cases[J].Int J Med Sci,2013,10(12):1602-1607. [5] Sun M, Shen Y, Ren ML, et al. Meta-analysis on the performance of p16/Ki-67 dual immunostaining in detecting high-grade cervical intraepithelial neoplasm[J].J Cancer Res Ther,2018,14(Supplement):S587-S593. [6] 包鹤龄,赵振平,张梅, 等.中国农村子宫颈癌筛查实施5年对人群筛查率的影响[J].中华预防医学杂志,2018,52(3):260-264. [7] 王海瑞,廖光东,江宇, 等.p16/mcm2双染在宫颈上皮内瘤变的诊断价值及其与高危型HPV感染的关系[J].中华流行病学杂志,2017,38(9):1241-1245. [8] Ikenberg H, Bergeron C, Schmidt D, et al. Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the PALMS study[J].J Natl Cancer Inst,2013,105(20):1550-1557. [9] 王海瑞,廖光东,陈汶, 等.p16/Ki-67免疫细胞化学双染在宫颈癌筛查中的应用价值[J].中华肿瘤杂志,2017,39(8):636-640.
2020, Vol. 37 
